Cardiovascular

At RemediumOne, we have extensive experience in executing successful cardiovascular clinical trials. We understand that cardiovascular disease (CVD) is a significant health issue globally, and Sri Lanka is no exception. It includes conditions such as heart disease, stroke, and other disorders that affect the heart and blood vessels. CVD has been a leading cause of morbidity and mortality in Sri Lanka for several years, and we’re committed to advancing the science in this critical therapeutic area.

We specialize in cardiovascular clinical research and have a successful track record of delivering on-time high-quality trials. Our team is equipped with extensive knowledge and experience to help medium and smaller mission-aligned biotech companies accelerate their trials while working within budgetary constraints.

Our team has worked on clinical trials across the spectrum of cardiovascular diseases, including hypertension, heart failure, coronary artery disease, and more. We have a deep understanding of the complex regulatory requirements and clinical trial design considerations that are unique to this therapeutic area.

• Hypertension
• Atrial fibrillation
• Stable angina
• Acute coronary syndrome
• Heart failure
• Dyslipidemia
• Peripheral arterial disease
• Stroke prevention
• Thromboembolic disorders
• Valvular heart disease

Our work has been published in major cardiology journals, find the links below:

GMRx2 ACT: https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(24)01744-6/abstract

GMRx2 PCT: https://www.acc.org/latest-in-cardiology/clinical-trials/2024/12/17/15/50/gmrx2-pct

ODYSSEY Trial: https://www.nejm.org/doi/full/10.1056/NEJMoa1801174

TRIUMPH:  https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(19)30343-2/fulltext

COBRA-BPS: https://www.nejm.org/doi/full/10.1056/NEJMoa1911965

HFrEF Polypill study: https://bmjopen.bmj.com/content/bmjopen/15/7/e100952.full.pdf